Cancer Research

The medical community is navigating a period where surviving a terminal diagnosis no longer guarantees a life free from severe physiological repercussions due to the unintended consequences of high-potency treatments. Oncology has entered a golden age of precision medicine and immunotherapy, yet

The traditional understanding of the immune system often places T cells as the primary assassins of malignancy, leaving other cells to perform the menial tasks of biological waste management. For many decades, the medical community viewed macrophages as simple cellular janitors that were only

The persistent struggle to eradicate aggressive malignant tumors often hinges on the cellular ability to withstand the intense biological stress inflicted by conventional therapeutic interventions like radiation. For decades, oncologists identified the insulin-like growth factor 1 receptor,

The conventional diagnostic approach of treating a tumor as a uniform mass of malignant cells has reached a functional ceiling in oncology, necessitating a move toward high-resolution architectural mapping. The Spatial Transcriptomic Tumor Atlas represents a pivotal shift in this landscape, moving

The quest to understand how malignant cells detach from a primary tumor and successfully colonize distant organs has long remained one of the most formidable challenges in modern oncology. While traditional therapies often succeed in shrinking localized masses, the ability of certain cells to evade

The traditional reliance on non-selective systemic chemotherapy for treating advanced gynecological malignancies is rapidly fading as clinicians embrace the precision of antibody–drug conjugates. For decades, the standard approach to ovarian, cervical, and endometrial cancers involved cytotoxic